Moderate to Severe IBD Pediatric Clinical Trial Near Garland PA

Is your child currently experiencing ulcerative colitis flare-ups? Local Crohn’s disease study is testing a potential new medication to see if it may reduce chronic diarrhea, unexplained weight loss, bloody stool, malnutrition, and/or liver disease associated with ulcerative colitis.
If you’re concerned about how ulcerative colitis affects your child’s life, find out more about the Crohn’s disease study.

Your child may be eligible for one of the GI studies if they are 2‒17 years of age, have been diagnosed with moderate to severe UC or CD, and have previously received treatment for UC or CD that has not worked.

By joining the GI studies, your child may receive:

  • Compensation for study-related time
  • Reimbursement for study-related travel
  • Study-related care from local doctors
  • Study medication at no cost

Health insurance is not required to take part.

Enrollment is limited so act quickly.

Moderate to Severe Crohn’s Disease Pediatric Clinical Trial Near Girard PA

We are looking for children and teens 2–17 years of age to join a Crohn’s disease clinical research to help us discover more about treating ulcerative colitis. If you are looking for a potential new treatment option for ulcerative colitis or gastrointestinal disease (including associated symptoms such as cramps, reduced appetite, abdominal pain, weight loss and/or anemia), consider one of our Crohn’s disease studies. All eligible participants will receive no-cost study-related care and study medication. Your children and teens 2–17 years of age may be eligible to take part.

Your child may be eligible to take part in the Crohn’s disease studies if they:

  • are 2‒17 years of age
  • have been diagnosed with moderate to severe ulcerative colitis (UC) or Crohn’s disease (CD)
  • have previously received treatment for UC or CD that has not worked.

See if your child qualifies.

Moderate to Severe Crohn’s Disease Pediatric Clinical Trial Near Grand Valley PA

Is your child currently experiencing moderate to severe Crohn’s disease flare-ups? Local Crohn’s disease trial is testing a potential new medication to see if it may reduce bloody diarrhea, diarrhea, rectal pain, malnutrition, and/or liver disease associated with moderate to severe Crohn’s disease.
If you’re concerned about how moderate to severe Crohn’s disease affects your child’s life, find out more about the Crohn’s disease trial.

Your child may be eligible for one of the GI studies if they are 2‒17 years of age, have been diagnosed with moderate to severe UC or CD, and have previously received treatment for UC or CD that has not worked.

By joining the GI studies, your child may receive:

  • Compensation for study-related time
  • Reimbursement for study-related travel
  • Study-related care from local doctors
  • Study medication at no cost

Health insurance is not required to take part.

See if your child qualifies.

Crohn’s Disease Pediatric Clinical Trial Near Harborcreek PA

We are looking for children 2–17 years of age to join a trial to help us discover more about treating Crohn’s disease. If you are looking for a potential new treatment option for Crohn’s disease or Crohn’s disease (CD) (including associated symptoms such as diarrhea with pus, reduced appetite, bloody stool, frequent fevers and/or anemia), consider one of our IBD research studies. All eligible participants will receive no-cost study-related care and study medication. Your children 2–17 years of age may be eligible to take part.

Your child may be eligible to take part in the IBD research studies if they:

  • are 2‒17 years of age
  • have been diagnosed with moderate to severe ulcerative colitis (UC) or Crohn’s disease (CD)
  • have previously received treatment for UC or CD that has not worked.

Find out if your child may be able to to join.

Moderate to Severe UC Pediatric Clinical Trial Near Harmonsburg PA

Is your child currently experiencing moderately to severely active ulcerative colitis flare-ups? Local Crohn’s disease clinical trial is testing a potential new medication to see if it may reduce bloody diarrhea, kidney stones, diarrhea, weight loss, and/or canker sores associated with moderately to severely active ulcerative colitis.
If you’re concerned about how moderately to severely active ulcerative colitis affects your child’s life, find out more about the Crohn’s disease clinical trial.

Your child may be eligible for one of the GI studies if they are 2‒17 years of age, have been diagnosed with moderate to severe UC or CD, and have previously received treatment for UC or CD that has not worked.

By joining the GI studies, your child may receive:

  • Compensation for study-related time
  • Reimbursement for study-related travel
  • Study-related care from local doctors
  • Study medication at no cost

Health insurance is not required to take part.

Find out if your child may be able to to join.

Moderate to Severe Crohn’s Disease Pediatric Clinical Trial Near Lake City PA

We are looking for children 2 to 17 years of age to join a CD clinical research to help us discover more about treating moderate to severe UC. If you are looking for a potential new treatment option for moderate to severe UC or Crohn’s and UC (including associated symptoms such as rectal pain, weight loss, abdominal pain, chronic fatigue and/or liver disease), consider one of our medical research studies. All eligible participants will receive no-cost study-related care and study medication. Your children 2 to 17 years of age may be eligible to take part.

Your child may be eligible to take part in the medical research studies if they:

  • are 2‒17 years of age
  • have been diagnosed with moderate to severe ulcerative colitis (UC) or Crohn’s disease (CD)
  • have previously received treatment for UC or CD that has not worked.

Act now.

Moderate to Severe UC Pediatric Clinical Trial Near Linesville PA

Is your child currently experiencing moderately to severely active IBD flare-ups? Local Crohn’s disease (CD) research is testing a potential new medication to see if it may reduce diarrhea, reduced appetite, diarrhea, chronic fatigue, and/or joint pain associated with moderately to severely active IBD.
If you’re concerned about how moderately to severely active IBD affects your child’s life, find out more about the Crohn’s disease (CD) research.

Your child may be eligible for one of the GI studies if they are 2‒17 years of age, have been diagnosed with moderate to severe UC or CD, and have previously received treatment for UC or CD that has not worked.

By joining the GI studies, your child may receive:

  • Compensation for study-related time
  • Reimbursement for study-related travel
  • Study-related care from local doctors
  • Study medication at no cost

Health insurance is not required to take part.

Act now.

Crohn’s Disease Pediatric Clinical Trial Near Mc Kean PA

We are looking for children and teens 2–17 years of age to join a Crohn’s disease (CD) study to help us discover more about treating Crohn’s disease (CD). If you are looking for a potential new treatment option for Crohn’s disease (CD) or Crohn’s (including associated symptoms such as rectal pain, growth failure, constant need to poop, malnutrition and/or eye pain), consider one of our GI research studies. All eligible participants will receive no-cost study-related care and study medication. Your children and teens 2–17 years of age may be eligible to take part.

Your child may be eligible to take part in the GI research studies if they:

  • are 2‒17 years of age
  • have been diagnosed with moderate to severe ulcerative colitis (UC) or Crohn’s disease (CD)
  • have previously received treatment for UC or CD that has not worked.

See if your child qualifies.

Moderate to Severe CD Pediatric Clinical Trial Near Mill Village PA

Is your child currently experiencing inflammatory bowel disease flare-ups? Local Crohn’s disease (CD) study is testing a potential new medication to see if it may reduce diarrhea with blood and pus, inflammation of the bowel or intestine, cramps, chronic fatigue, and/or joint pain associated with inflammatory bowel disease.
If you’re concerned about how inflammatory bowel disease affects your child’s life, find out more about the Crohn’s disease (CD) study.

Your child may be eligible for one of the GI studies if they are 2‒17 years of age, have been diagnosed with moderate to severe UC or CD, and have previously received treatment for UC or CD that has not worked.

By joining the GI studies, your child may receive:

  • Compensation for study-related time
  • Reimbursement for study-related travel
  • Study-related care from local doctors
  • Study medication at no cost

Health insurance is not required to take part.

See if your child qualifies.

Moderate to Severe UC Pediatric Clinical Trial Near North East PA

We are looking for young people at least 2 years of age but under 18 to join a Crohn’s disease research to help us discover more about treating CD and UC. If you are looking for a potential new treatment option for CD and UC or CD (including associated symptoms such as diarrhea with blood and pus, unexplained weight loss, constant need to poop, weight loss and/or joint pain), consider one of our clinical trials. All eligible participants will receive no-cost study-related care and study medication. Your young people at least 2 years of age but under 18 may be eligible to take part.

Your child may be eligible to take part in the clinical trials if they:

  • are 2‒17 years of age
  • have been diagnosed with moderate to severe ulcerative colitis (UC) or Crohn’s disease (CD)
  • have previously received treatment for UC or CD that has not worked.

Enrollment is limited, so please respond now.